Aug 5, 2025 - Business

Former X CEO Linda Yaccarino named CEO of GLP-1 telehealth company

Nathan Bomey

Woman in a light purple blazer with black glasses and a necklace holds a phone and talks to a man with long blond hair in a crowd outdoors during the day. — Linda Yaccarino, then serving as CEO of Elon Musk's X, attends a bipartisan bill signing ceremony at the White House in May. Photo: Samuel Corum/Bloomberg via Getty Images

Linda Yaccarino has a new job in a vastly different industry weeks after her exit as CEO of X, Elon Musk's social discourse app.

Why it matters: Musk hired the former NBCUniversal ad boss as the first permanent CEO of the platform formerly known as Twitter after he acquired it in 2022.

She left X in July after a tumultuous tenure in which she repeatedly defended Musk while trying to convince displeased marketers to continue advertising on the platform.

Driving the news: Yaccarino is the new CEO of eMed Population Health, a telehealth focused on GLP-1s, the blockbuster drugs used to treat diabetes and obesity.

"There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before," Yaccarino said in a statement.

Zoom in: Yaccarino comes on board as eMed is aiming to expand partnerships with employers and governments.

"Her ability to forge game-changing partnerships and navigate complex markets will position the company to become the definitive global leader in population health solutions," eMed said in a statement.
She replaces Wendi Mader, who spent about a year in the CEO role after previously serving as an executive at Quest Diagnostics.

Add Axios on Google

Former X CEO Linda Yaccarino named CEO of GLP-1 telehealth company

What to read next